Test Price
2,800 AED✅ Home Collection Available
SERPINH1 Gene Osteogenesis Imperfecta Type 10 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SERPINH1 لمرض تكون العظم الناقص من النوع 10 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🏆 DHA-Approved Genetic Profiling – Unmatched Accuracy & UAE Compliance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS & Sanger Validation.
- Premium Logistics: Paid Hospital-Grade Home Collection (8 AM–11 PM) with ISO-Certified Cold-Chain Transport & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-Licensed Genetic Counsellor for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الفحص الجيني المعتمد من هيئة الصحة بدبي
دقة تشخيصية 99.9%، استشارة وراثية مهنية بعد النتيجة، وسحب منزلي آمن وفق معايير الآيزو. التحليل يغطي طفرة جين SERPINH1 المرتبطة بتكوّن العظم الناقص النوع 10، مع دعم مباشر للفوترة التأمينية.
Overview of the SERPINH1 Gene Test
SERPINH1 gene sequencing is the definitive molecular diagnostic tool for Osteogenesis Imperfecta Type 10, a severe autosomal recessive collagenopathy. This next‑generation sequencing (NGS) test analyzes the entire coding region of SERPINH1 (HSP47) for pathogenic variants, enabling accurate diagnosis, carrier screening, and personalized management planning under 2026 DHA genetic testing protocols.
يُعد تحليل جين SERPINH1 الاختبار الجزيئي الحاسم لتشخيص مرض تكون العظم الناقص من النوع 10، باستخدام تقنية التسلسل من الجيل التالي (NGS) وفق أحدث إرشادات هيئة الصحة بدبي لعام 2026.
| Feature | 🇦🇪 Our SERPINH1 NGS Test | Closest Alternative (Sanger Sequencing Only) |
|---|---|---|
| Precision | Full gene coverage + copy number variant detection (99.9% sensitivity) | Targeted amplicons only; may miss deep intronic or regulatory variants |
| Method | NGS (Illumina NovaSeq) with Sanger confirmation of pathogenic calls | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 Weeks (Standard) | 4–6 Weeks |
Physician Insight & Safety Protocol
“As a DHA-licensed pathologist, I emphasize that a SERPINH1 genetic result must be interpreted within the full clinical and radiological context. A positive finding confirms the molecular diagnosis but does not replace thorough patient assessment and family counseling. Please always correlate with your specialist before making any treatment changes.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Do not discontinue prescribed medication or modify bone management plans without consulting your doctor. This test is for diagnostic and surveillance purposes only.
🚨 Patient Safety Exclusion Criteria & Red Flags
- Exclusion: Active infection or acute fracture at the time of blood draw (defer until stabilized).
- Exclusion: Inability to provide informed consent (legal guardian must sign for minors per CDS Law 2026).
- Red Flag: Sudden severe bone pain, new deformities, or loss of mobility – seek emergency orthopaedic evaluation immediately.
- Red Flag: Respiratory distress or chest wall abnormalities – possible OI-related pulmonary compromise, call 998.
Frequently Asked Questions (Patient Guidance)
Q: What does a positive SERPINH1 gene test mean for my child’s bone health?
A positive result confirms Osteogenesis Imperfecta Type 10, a genetic collagen disorder characterized by bone fragility, recurrent fractures, and often blue sclerae. It means your child carries two mutated copies of SERPINH1, requiring immediate multidisciplinary care from a pediatric orthopaedist and clinical geneticist to optimize bone strength and prevent fractures. (Always discuss findings with your DHA-licensed physician.)
يؤكد وجود طفرة جينية في جين SERPINH1 تشخيص مرض تكون العظم الناقص من النوع 10، مما يستدعي رعاية متخصصة فورية لتقوية العظام وتجنب الكسور.
Q: How is the sample collected and how long do results take?
A small blood sample (or DNA from a buccal swab/FTA card) is collected in a hospital-grade home visit or at our facility, with results available in 3 to 4 weeks. The sample is processed via NGS with Sanger validation for any detected variant, ensuring the highest clinical accuracy mandated by ISO 9001:2015.
يتم سحب عينة دم بسيطة في المنزل أو في المختبر، وتظهر النتائج خلال 3 إلى 4 أسابيع مع تأكيد دقيق بأحدث تقنيات التسلسل الجيني.
Q: Is this covered by UAE health insurance?
Many UAE insurers cover medically indicated genetic tests when accompanied by a specialist referral and pre-authorization. We provide direct billing verification through WhatsApp at +971 54 548 8731; our team will confirm coverage within one business day, and you can use our insurance facilitation to reduce out‑of‑pocket costs.
تغطي العديد من شركات التأمين في الإمارات هذا الفحص الجيني عند وجود إحالة طبية، ويمكن التحقق من التغطية عبر الواتساب.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians